Breast cancer screening: The debate that never ends

Sarah Maier Friedewald*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Screening mammography has been shown to decrease breast cancer deaths through randomized controlled trials. However, there remains significant debate surrounding the most appropriate time to commence screening and the optimal screening interval. Several national organizations have recently updated their guidelines by reanalyzing the published data. Interestingly, each organization has come to different conclusions regarding their recommendation for breast cancer screening in the average risk woman. Three of the main organizations that issue guidelines for breast cancer screening in the United States are reviewd in this chapter.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherSpringer International Publishing
Pages31-38
Number of pages8
DOIs
Publication statusPublished - Jan 1 2018

Publication series

NameCancer Treatment and Research
Volume173
ISSN (Print)0927-3042

    Fingerprint

Keywords

  • Breast imaging
  • Mammography
  • Randomized controlled trials
  • Screening

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Friedewald, S. M. (2018). Breast cancer screening: The debate that never ends. In Cancer Treatment and Research (pp. 31-38). (Cancer Treatment and Research; Vol. 173). Springer International Publishing. https://doi.org/10.1007/978-3-319-70197-4_3